Literature DB >> 18074060

Non-Hodgkin's lymphoma in childhood: clinical and epidemiological characteristics and survival analysis at a single center in Northeast Brazil.

Marcia Ferreira Pedrosa1, Francisco Pedrosa, Mecneide M Lins, Nicodemus T Pontes Neto, Gilliatt Hanois Falbo.   

Abstract

OBJECTIVE: To describe the clinical and demographic characteristics of non-Hodgkin's lymphoma patients diagnosed at the Pediatric Oncology Unit at the Instituto Materno-Infantil Professor Fernando Figueira (IMIP) over a 9-year period, and also to describe their survival rates and possible associations between the survival rates and the clinical and demographic characteristics analyzed in the study.
METHODS: This was a cross-sectional study. Data were collected by a retrospective review of the charts of all 110 patients admitted to our unit during the period of May 1994 through May 2003. Probability of survival was calculated in accordance with the techniques of Kaplan-Meier, using log rank to evaluate differences between the groups.
RESULTS: The average age was 6.1 years. The male/female ratio was 2.4:1. The most frequent histological subtype was Burkitt's lymphoma. The majority of patients had been diagnosed with advanced disease (stage III or IV of Murphy's Classification) and was from rural areas. Family income per capita was lower than 1/2 minimum wage in 36.4% of cases; maternal illiteracy was observed in 12.7% of cases. The 5-year overall survival and disease-free survival rates were 70+/-4% and 68.4+/-4%, respectively. None of the clinical-demographic characteristics had a significant association with the probability of survival (p > 0.05).
CONCLUSION: Children admitted to the IMIP seemed to be affected by non-Hodgkin lymphoma at a younger age, with a higher incidence of Burkitt's lymphoma and with survival rates similar to those described in the literature of developed countries. No clinical demographic characteristics had a statistically significant association with prognosis

Entities:  

Mesh:

Year:  2007        PMID: 18074060     DOI: 10.2223/JPED.1726

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  7 in total

1.  Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India.

Authors:  Marie Therese Manipadam; Sheila Nair; Auro Viswabandya; Leni Mathew; Alok Srivastava; Mammen Chandy
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Prognostic significance of biochemical markers in African Burkitt's lymphoma.

Authors:  F K N Arthur; L Owusu; F A Yeboah; T Rettig; A Osei-Akoto
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

3.  Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.

Authors:  Laila M Sherief; Usama R Elsafy; Elhamy R Abdelkhalek; Naglaa M Kamal; Doaa M Youssef; Rabab Elbehedy
Journal:  Mol Clin Oncol       Date:  2014-09-24

Review 4.  Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income Countries.

Authors:  Raul C Ribeiro; Federico Antillon; Francisco Pedrosa; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

5.  Pediatric lymphomas in Brazil.

Authors:  Gabriela Gualco; Claudete E Klumb; Glen N Barber; Lawrence M Weiss; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Non Hodgkin Lymphoma Among Children: Pathological Aspects and Diagnostic Challenges.

Authors:  Sabrine Derqaoui; Ismail Boujida; Oussama Marbouh; Lamiaa Rouas; Laila Hessissen; Najat Lamalmi
Journal:  Clin Pathol       Date:  2022-04-17

Review 7.  Low socioeconomic status is associated with worse survival in children with cancer: a systematic review.

Authors:  Sumit Gupta; Marta Wilejto; Jason D Pole; Astrid Guttmann; Lillian Sung
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.